Raven biosciences ApS — Credit Rating and Financial Key Figures

CVR number: 39085127
Åbogade 15, 8200 Aarhus N
kgj@ravenbiosciences.com
tel: 23490227
ravenbiosciences.com

Company information

Official name
Raven biosciences ApS
Personnel
6 persons
Established
2017
Company form
Private limited company
Industry

About Raven biosciences ApS

Raven biosciences ApS (CVR number: 39085127) is a company from AARHUS. The company reported a net sales of 5.1 mDKK in 2024, demonstrating a decline of -27.8 % compared to the previous year. The operating profit percentage was poor at -24.4 % (EBIT: -1.2 mDKK), while net earnings were -925.2 kDKK. The profitability of the company measured by Return on Assets (ROA) was -18.1 %, which can be considered poor and Return on Equity (ROE) was -32.4 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 34 %, a level that can be considered to be low. This means a higher proportion of debt in its capital structure, indicating a greater reliance on borrowed funds. Raven biosciences ApS's liquidity measured by quick ratio was 1.5 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.

Financial information

See financials

Net sales (kDKK)

EBIT (kDKK)

Profitability

Solidity

Key figures (kDKK)

See financials
2020
2021
2022
2023
2024
Volume
Net sales2 243.535 956.8612 670.197 055.105 095.38
Gross profit2 104.793 398.527 482.865 992.864 114.84
EBIT- 321.51918.033 482.70732.81-1 242.52
Net earnings- 255.47710.152 477.56429.53- 925.20
Shareholders equity total413.041 015.093 492.663 921.951 796.75
Balance sheet total (assets)974.522 986.797 938.957 284.875 278.14
Net debt- 405.54- 709.51-2 774.48-6 094.27-3 490.05
Profitability
EBIT-%-14.3 %15.4 %27.5 %10.4 %-24.4 %
ROA-30.7 %46.4 %67.1 %10.8 %-18.1 %
ROE-47.2 %99.5 %109.9 %11.6 %-32.4 %
ROI-59.5 %128.6 %162.7 %22.2 %-39.8 %
Economic value added (EVA)- 284.37695.312 665.00607.13-1 166.24
Solvency
Equity ratio42.4 %34.0 %44.0 %53.8 %34.0 %
Gearing
Relative net indebtedness %7.0 %21.2 %13.2 %-38.7 %-0.2 %
Liquidity
Quick ratio1.71.51.82.21.5
Current ratio1.71.51.82.21.5
Cash and cash equivalents405.54709.512 774.486 094.273 490.05
Capital use efficiency
Trade debtors turnover (days)71.8127.3135.133.067.4
Net working capital %18.4 %17.0 %27.6 %55.6 %35.3 %
Credit risk
Credit ratingBBBBBBBBBBBBBB

Variable visualization

ROA:-18.1%
Rating: 2/100
-20%
0%
4%
11%
24%
60%
Graph showing the distribution of the variable
Equity ratio:34.0%
Rating: 29/100
-1%
21%
50%
81%
99%
100%
Graph showing the distribution of the variable

Roles

Chief executive officer
Chief executive officer

Companies in the same industry

Try the full version of our system for free
Bankruptcy risk visualization example

... and more!

No registration needed.